Reactivity of purified GP40 antigen with antibodies from sera of patients with colorectal cancer: A follow‐up study

Yair Gazitt, Z. Bentwich, A. Shani

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

A glycoprotein antigen (GP40) was previously identified as a major component of immune complexes isolated from sera of patients with Burkitt's lymphoma. Its reactivity with antibodies from sera of patients with various types of cancer was described. In this presentation we describe the methods for further purification of GP40 from Burkitt's lymphoma sera. Radioiodinated purified GP40 was used in a double antibody precipitation assay, to measure the level of free anti‐GP40 antibodies in sera of patients with colorectal cancer. Follow‐up studies of patients at various stages of the disease revealed a close correlation between the level of free anti‐GP40 antibodies and the stage of the disease, namely, low levels in advanced stages (C‐D) and high levels in early stages (A‐B). Furthermore, patients in remission undergoing chemotherapy always had elevated levels of free antibodies. Similarly, patients in relapse had decreasing levels of free antibodies.

Original languageEnglish
Pages (from-to)537-541
Number of pages5
JournalInternational Journal of Cancer
Volume32
Issue number5
DOIs
StatePublished - 1 Jan 1983
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Reactivity of purified GP40 antigen with antibodies from sera of patients with colorectal cancer: A follow‐up study'. Together they form a unique fingerprint.

Cite this